Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Climacteric ; 19(4): 375-80, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27174039

RESUMEN

OBJECTIVE: To identify women's sociodemographic and variables related to health care with the prescription of hormonal therapy (HT) and phytotherapy (PT) in Spanish postmenopausal women. METHOD: The survey consisted of a multicenter, observational, cross-sectional, questionnaire-based investigation and was conducted among 3022 postmenopausal women. RESULTS: Of all the women, 31.8% reported the use of systemic HT or PT sometime in their lives. Hot flushes and information received about menopause were the most important variables that influence HT and PT use, although far more intense symptoms were observed in those who were inclined to use HT. The use of HT or PT was more frequently reported among women with high levels of education, who came from private clinics and lived in urban areas. Women who had primary ovarian insufficiency or surgical menopause were inclined to use HT. CONCLUSION: Hot flushes and information received about menopause are the most important variables that influence HT and PT use.


Asunto(s)
Conducta de Elección , Terapia de Reemplazo de Estrógeno/psicología , Conocimientos, Actitudes y Práctica en Salud , Fitoterapia/psicología , Posmenopausia/psicología , Estudios Transversales , Escolaridad , Femenino , Sofocos/tratamiento farmacológico , Humanos , Persona de Mediana Edad , España , Encuestas y Cuestionarios
2.
Climacteric ; 18(6): 813-6, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26455645

RESUMEN

BACKGROUND: DT56a (Femarelle®) is a natural medication that contains a variety of phytoestrogens derived from tofu. Treatment with DT56a affects bones, vascular tissues and the nervous system in a manner similar to that of estrogen but DT56a acts as an estrogen antagonist in breast and uterine tissues. AIM: The objective of this study was to analyze the efficacy of DT56a in the reduction of menopause symptoms in Spanish women who participated in the Post Marketing Menopausal Symptoms International Survey (POMMSIS). PATIENTS AND METHODS: A total of 631 Spanish menopausal or perimenopausal women with vasomotor symptoms who took DT56a for 4 weeks participated in this study. This study was an observational, questionnaire-based investigation that consisted of a baseline questionnaire, a hot flushes daily diary and a feedback questionnaire. RESULTS: A statistically significant (p < 0.01) reduction in the number and intensity of hot flushes was experienced after 2 and 4 weeks of DT56a treatment. After 4 weeks of treatment with DT56a, 80.7% of the patients reported that their hot flushes were 'better' or 'much better'. The severity of hot flushes was also reduced by 38% in all study participants and by 36% in women who had experienced more than seven hot flushes per day initially, before treatment. CONCLUSION: Treatment with DT56a resulted in a significant reduction in the number and intensity of hot flushes in postmenopausal women, especially in those with frequent symptoms, and these effects were observed within the first month of treatment.


Asunto(s)
Sofocos/tratamiento farmacológico , Menopausia , Fitoestrógenos/uso terapéutico , Extractos Vegetales/uso terapéutico , Femenino , Humanos , Persona de Mediana Edad , Estudios Prospectivos , Calidad de Vida , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios
3.
Climacteric ; 18(3): 350-7, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25236805

RESUMEN

In this review, we analyze the efficacy and safety of DT56a in the treatment of postmenopausal symptoms. Similar to all selective estrogen receptor modulators (SERMs), DT56a demonstrates dual agonistic and antagonistic effects due to the synergy between its components. DT56a is referred to as a plant-origin SERM (phyto-SERM) and, for this reason, its therapeutic capacity in postmenopausal women differs from other phytoestrogens used independently. Although interesting data on relief of vasomotor symptoms have been reported for DT56a, further clinical studies with a greater number of cases and a longer period of study are required to correctly identify its indications for use as an alternative to hormone therapy, especially in preventing osteoporosis.


Asunto(s)
Fitoestrógenos/farmacología , Fitoterapia , Extractos Vegetales/farmacología , Posmenopausia/efectos de los fármacos , Moduladores Selectivos de los Receptores de Estrógeno/farmacología , Densidad Ósea/efectos de los fármacos , Sistema Cardiovascular/efectos de los fármacos , Femenino , Humanos , Fitoestrógenos/efectos adversos , Extractos Vegetales/efectos adversos , Moduladores Selectivos de los Receptores de Estrógeno/efectos adversos , Sistema Vasomotor/efectos de los fármacos
4.
Zygote ; 21(2): 110-4, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-22067745

RESUMEN

Summary The objective of the present study was to evaluate the viability of frozen embryos obtained from various private farmers in a culture medium for 4 h. Forty-seven embryos were used that had been previously graded as good and fair. These embryos were evaluated using stereoscopic microscopy by experienced clinicians prior to freezing. Embryos were divided in two groups: the non-cultured group, made up of six good quality embryos, and five fair; and the cultured group that consisted of 20 good quality embryos and 16 fair. Fifty-four per cent of the good quality embryos achieved a favourable development during culture whereas just 42% of embryos determined to be fair were observed to have adequate development. This evaluation was undertaken by serial photographs obtained at the onset of culture and 4 h later. This finding was corroborated by a more specific technique: terminal deoxynucleotide transferase dUTP nick end labelling-bromodeoxyuridine (TUNEL-BrdU). These results are indicative of the necessity of tight quality controls for commercially produced frozen embryos, as once thawed it is unlikely that clinicians will examine them to determine their physiological status prior to transfer.


Asunto(s)
Apoptosis , Blastocisto/citología , Proliferación Celular , Criopreservación , Medios de Cultivo/química , Técnicas de Cultivo de Embriones , Embrión de Mamíferos/citología , Humanos , Etiquetado Corte-Fin in Situ , Microscopía Electrónica
5.
Food Chem Toxicol ; 49(11): 2855-61, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21839798

RESUMEN

D-004, a lipid extract of royal palm (Roystonea regia) fruits that contains a reproducible mixture of fatty acids, has been shown to prevent testosterone and phenylephrine-induced prostate hyperplasia in rodents. This study investigated the long-term oral toxicity of D-004 in rats. Rats from both sexes were randomized into four groups (20 rats sex/group): a control and three treated with D-004 (800, 1500 or 2000 mg/kg/day, respectively). At study completion, rats were sacrificed under anaesthesia. Determinations of blood biochemical and haematological parameters and organ weight were done. Also, necropsy and histopathological studies were performed. Four of 160 rats died before study completion. No clinical signs of toxicity were observed throughout the study. Food and water consumption, bodyweight, blood biochemical and haematological parameters, organ weight ratios and histopathological findings were similar in control and treated groups. The histological lesions found in treated animals are commonly present in this specie and strain according to literature and our historical data. In conclusion, long-term (12 months) oral treatment of rats with D-004 (800-2000 mg/kg/day) did not show evidences of D-004-related toxicity under our conditions. The highest dose tested (2000 mg/kg) was a no-observed adverse effect level in this study.


Asunto(s)
Arecaceae/química , Frutas/química , Extractos Vegetales/toxicidad , Administración Oral , Animales , Esquema de Medicación , Femenino , Masculino , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Ratas , Ratas Sprague-Dawley
6.
Reprod Domest Anim ; 45(6): e260-8, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19930134

RESUMEN

The objectives of this study were two. First, to compare three base media with different sugar composition as an initial step to achieve a good chemically-defined extender for ram sperm refrigeration. The second one, to determine which sperm quality parameters may be more useful for revealing differences between sperm samples. One medium contained 200 mM sucrose and 2.8 mM glucose (SM), another only disaccharides (D) such as sucrose, trehalose, maltose and lactose (75 mM each); and the third one (D+M) included a mix of monosaccharides (50 mM glucose, 20 mM fructose and 20 mM galactose,) and the same disaccharides as in D (50 mM each). Ram semen samples diluted in the mentioned media were refrigerated at 5°C for 1 h, and rewarmed upto 37°C in order to mimic the temperature in the female reproductive tract. Addition of monosaccharides to the extender did not produce a better preservation of motility or viability after cooling. The supplementation with other disaccharides apart from sucrose did not enhance the viability either. Thus, after cooling and rewarming, there were no significant differences in sperm viability (membrane integrity evaluated by CFDA/PI staining) or the percentage of progressive motile and rapid sperm (evaluated by CASA) between the three media. However, the percentage of viable non-capacitated sperm evaluated by the chlortetracycline (CTC) assay was higher and sperm oxygen consumption was lower in SM than in D and in D+M. Although the apoptosis-like markers [phosphatidylserine exposure assessed by Annexin V/CFDA staining and DNA-damage evaluated by TUNEL assay] showed a continuous increment throughout the process with all diluents, the percentage of sperm with damaged DNA at the end of the process was significantly lower in SM than in the other two media (p < 0.01). On the basis of these results, we would make two recommendations: the use of an extender supplemented only with sucrose and glucose for ram sperm refrigeration; the inclusion of non-conventional methods such as oxygen consumption measure, evaluation of capacitation state and apoptosis-like markers for revealing differences between sperm samples.


Asunto(s)
Criopreservación/veterinaria , Preservación de Semen/veterinaria , Ovinos/fisiología , Espermatozoides/efectos de los fármacos , Espermatozoides/fisiología , Animales , Supervivencia Celular , Frío , Fragmentación del ADN , Etiquetado Corte-Fin in Situ , Masculino , Consumo de Oxígeno , Fosfatidilserinas/metabolismo , Motilidad Espermática , Factores de Tiempo
7.
Rev. chil. pediatr ; 78(3): 261-267, jun. 2007. tab, graf
Artículo en Español | LILACS | ID: lil-473255

RESUMEN

Introducción: El adenovirus es un importante agente etiológico en infecciones respiratorias en niños, que en ocasiones puede producir una gran morbimortalidad. Objetivo: Describir las características clínicas y epidemiológicas de las infecciones respiratorias por ADV e identificar posibles factores de riesgo asociados a gravedad, mortalidad y secuelas broncopulmonares. Pacientes y Metodos: Se revisaron las fichas clínicas de los pacientes con diagnóstico de infección respiratoria por adenovirus mediante IFI durante 2004; se registraron datos epidemiológicos y clínicos; se evaluaron factores de riesgo y se calculó la tasa de ataque. Resultados: Se incluyeron 57 niños, 68,4 por ciento varones, mediana de edad de 10 meses, 67 por ciento menores de 1 año. 89,5 por ciento fueron hospitalizados; 26,3 por ciento evolucionó grave, 8,8 por ciento falleció y 47,3 por ciento presentó secuelas broncopulmonares. En este período se produjeron 2 brotes intrahospitalarios, con una tasa de ataque de 16,5 por ciento. Se identificaron como factores de riesgo para enfermedad grave: edad entre 4 y 10 meses y adquirir el ADV durante un brote intrahospitalario; para mortalidad el antecedente de enfermedad subyacente, y para secuelas pulmonares la edad entre 4 y 10 meses. Conclusiones: Los factores de riesgo identificados deben llamar nuestra atención en niños hospitalizados con diagnóstico de adenovirus ya que pueden predecir una evolución desfavorable.


Asunto(s)
Masculino , Femenino , Lactante , Preescolar , Humanos , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/virología , Infecciones por Adenoviridae/epidemiología , Evolución Clínica , Estudios de Cohortes , Estudios de Seguimiento , Infección Hospitalaria/epidemiología , Infección Hospitalaria/virología , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones por Adenoviridae/complicaciones , Infecciones por Adenoviridae/diagnóstico , Factores de Riesgo , Estaciones del Año
8.
Drugs R D ; 7(4): 233-41, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16784248

RESUMEN

BACKGROUND AND OBJECTIVE: Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate that results in obstructive lower urinary tract symptoms. Saw palmetto (Serenoa repens), the dwarf American palm (Arecaceae family), is commonly used to treat BPH. The Cuban royal palm (Roystonea regia) also belongs to the Arecaceae family, and 200-400mg of D-004, a lipid extract from its fruits, administered orally for 14 days has been shown to prevent testosterone- but not dihydrotestosterone-induced prostatic hyperplasia in rats. D-004 (125-250 microg/mL) added to preparations of rat vas deferens caused a marked, dose-dependent and significant inhibition of noradrenaline-induced smooth muscle contraction, a response mediated through alpha(1)-adrenoceptors, and was more effective in these respects than Saw palmetto. However, the in vivo effects of D-004 and Saw palmetto on the hypertensive response induced by noradrenaline were modest (albeit significant), and neither treatment affected resting blood pressure or heart rate in rats. The differential effects of D-004 in in vitro and in vivo models could be related to a differential affinity for adrenoceptor subtypes or to different bioavailabilities in vascular and urogenital targets. Phenylephrine injected into rodents induces prostatic hyperplasia with all the characteristic morphological changes of the condition but does not result in enlargement of the prostate. Therefore, this phenylephrine-induced change in rat prostate tissue is called atypical prostatic hyperplasia. It serves as an in vivo model of prostatic hyperplasia induced by stimulation of alpha(1)-adrenoceptors. The objective of this study was to determine whether D-004 can inhibit induction of atypical prostatic hyperplasia by phenylephrine in rats. METHODS: Rats were randomly distributed into five groups (ten rats/group). One group was a negative control and received oral vehicle only. The other four groups were injected subcutaneously with phenylephrine (2 mg/kg): of these groups, one was a positive control receiving the vehicle, and the other three groups were treated with D-004 or Saw palmetto (both 400 mg/kg) or tamsulosin 0.4 mg/kg. All active treatments were given orally for 28 days. After completion of treatment, rats were placed unrestrained in metabolic cages and micturition studies were performed. The rats were later killed and their prostates removed and weighed. Prostate samples were processed for histological study, with histological changes being assessed according to a scoring system. Bodyweight was measured at baseline and at weekly intervals. RESULTS: Histological examination of positive control rats revealed features of atypical prostatic hyperplasia, with piling-up, papillary and cribiform patterns and budding-out of epithelial cells. Micturition assessment revealed that phenylephrine significantly lowered both the total volume of urine in 1 hour and the volume per micturition; the latter was considered the main efficacy variable. D-004 and Saw palmetto extracts significantly prevented this reduction in volume per micturition by 70.5% and 68.6%, respectively, while tamsulosin totally abolished the reduction in micturition induced by phenylephrine (100% inhibition). Tamsulosin, D-004 and Saw palmetto significantly reduced the histological changes of atypical prostatic hyperplasia induced by phenylephrine by 73.1%, 61.2% and 50.0%, respectively. CONCLUSIONS: Administration of D-004 resulted in marked and significant prevention of phenylephrine-induced impairment of micturition and histological changes in rat prostate. These findings indicate that, in vivo, D-004 effectively opposes these responses to phenylephrine, which are mediated through urogenital alpha(1)-adrenoceptors. In this respect, D-004 was moderately more effective than Saw palmetto, a phytotherapeutic standard used to treat BPH, but less effective than tamsulosin, a selective alpha(1A)-adrenoceptor antagonist.


Asunto(s)
Arecaceae/química , Extractos Vegetales/uso terapéutico , Hiperplasia Prostática/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Frutas/química , Masculino , Fenilefrina/química , Extractos Vegetales/administración & dosificación , Extractos Vegetales/aislamiento & purificación , Hiperplasia Prostática/inducido químicamente , Hiperplasia Prostática/patología , Ratas , Ratas Sprague-Dawley
9.
Drugs Exp Clin Res ; 30(3): 117-23, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15366788

RESUMEN

Osteoporosis is characterized by reduced bone mass, abnormal bone architecture and increased fracture risk. Ovariectomy impairs bone mass and metabolism in rats and ovariectomized rats are considered as a suitable model of postmenopausal osteoporosis. Mevalonate is required for producing lipoids that are important in osteoclast activity and thus drugs affecting mevalonate production can prevent bone loss in rodents. Policosanol is a cholesterol-lowering drug isolated from sugar cane wax that inhibits cholesterol biosynthesis through an indirect regulation of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase activity. The purpose of this study was to determine whether policosanol could prevent bone loss in the bones of ovariectomized rats by comparing its effects with those induced by estradiol. Sprague Dawley female rats were randomly distributed in four groups: a sham-operated group treated with Tween/H2O vehicle and three groups of ovariectomized rats treated with 17beta-estradiol (30 microg/kg/day) or policosanol (50 and 200 mg/kg/day), respectively, for 3 months. At treatment completion the rats were sacrificed, their bones removed and variables of bone resorption and formation were investigated by histomorphometry. Ovariectomy increased trabecular separation but diminished the number and thickness of trabecules. Estradiol and policosanol prevented these effects compared with ovariectomized controls. Both treatments also prevented an increase in the number of osteoclasts and their surface area induced by ovariectomy. Estradiol, but not policosanol, significantly prevented an increase of osteoblast surface area compared with ovariectomized controls. In conclusion, policosanol prevented bone loss and decreased bone resorption in ovariectomized rats, suggesting that it should be potentially useful in preventing bone loss in postmenopausal women.


Asunto(s)
Alcoholes Grasos/farmacología , Osteoporosis/prevención & control , Ovariectomía , Administración Oral , Animales , Modelos Animales de Enfermedad , Esquema de Medicación , Evaluación Preclínica de Medicamentos/métodos , Estradiol/administración & dosificación , Estradiol/farmacocinética , Alcoholes Grasos/administración & dosificación , Alcoholes Grasos/química , Femenino , Humanos , Inyecciones Subcutáneas , Intubación Gastrointestinal , Osteoclastos/efectos de los fármacos , Osteoporosis/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Ratas , Ratas Sprague-Dawley
10.
Int J Tissue React ; 25(3): 91-8, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14756190

RESUMEN

D-003 is a mixture of very high molecular weight aliphatic primary acids purified from sugar cane (Saccharum officinarum, L) wax, in which the most abundant component is octacosanoic acid. Experimental studies have shown that D-003 not only shows cholesterol-lowering and antiplatelet effects, but also offers strong protection against plasma lipoprotein oxidation. Previous studies demonstrated that D-003 protected against the histological changes characteristic of Cl4C-induced hepatic injury in rats. The aim of the present study was to investigate the effects of D-003 in acute hepatotoxicity induced by paracetamol in rats. Male Sprague Dawley rats were randomly distributed in two experimental series of three experimental groups as follows: group 1--positive control rats (paracetamol-treated); groups 2 and 3--rats with liver damage induced by paracetamol and treated with D-003 at 5 and 25 mg/kg, respectively, and which also received paracetamol to induce liver injury. In experimental series 1, animals received paracetamol orally (600 mg/kg). In series 2, paracetamol was administered through the intraperitoneal route (200 mg/kg). Eighteen hours after paracetamol dosing, rats were anesthetized with ether and livers were removed for histopathological studies. In the two experimental series, D-003 at 5 and 25 mg/kg significantly (p < 0.01) decreased the percentage of turgent cells and hepatocytes with necrosis and increased the percentage of normal hepatocytes with respect to positive controls in a dose-dependent manner. Necrotic areas and inflammatory infiltrates were observed in the liver of nine out of ten (90%) positive controls. In turn, D-003 dramatically reduced both necrotic areas and inflammatory infiltrate and was present in only one out of ten (10%) animals treated in the two experimental series. No histological alterations in liver sections of negative controls were found. D-003 protected against the histological changes characteristic of paracetamol-induced hepatic injury in rats, in which the process of lipid peroxidation plays a major role. The relationship between this protective action of D-003 in this experimental model and its antioxidant effects needs to be further investigated before definitive conclusions are drawn.


Asunto(s)
Acetaminofén/toxicidad , Ácidos Grasos/uso terapéutico , Hígado/efectos de los fármacos , Fitoterapia , Saccharum/química , Ceras/química , Administración Oral , Animales , Esquema de Medicación , Evaluación Preclínica de Medicamentos , Ácidos Grasos/administración & dosificación , Ácidos Grasos/aislamiento & purificación , Hígado/patología , Masculino , Peso Molecular , Preparaciones de Plantas , Ratas , Ratas Sprague-Dawley
11.
Eur J Endocrinol ; 146(2): 231-5, 2002 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11834433

RESUMEN

OBJECTIVE: Assessment of the hypothalamic--pituitary--adrenal (HPA) axis relies on the interpretation of serum (total) cortisol in response to dynamic tests of the HPA axis. Most cortisol is bound to cortisol-binding globulin (CBG) and serum total cortisol levels are significantly affected by variation in CBG. We hypothesised that CBG variation significantly affects interpretation of dynamic tests of the HPA axis. DESIGN: We investigated the effect of CBG variation on the outcome of the 250 microg short Synacthen test (SST) in 30 healthy adults. METHODS: Blood was sampled at time -30, 0 (at which point Synacthen was given) and +30 min. CBG and total cortisol were measured at each time-point. Integrity of the HPA axis was confirmed by measurement of urine cortisol. RESULTS: We found that CBG varied significantly within individuals, falling from 51+/-3.4 to 43 +/-3.2 microg/ml (P<0.0001) on changing from standing to lying. Total cortisol levels strongly correlated with CBG (r=0.88, P<0.0001). Thirteen subjects had a +30 min total cortisol <550 nmol/l. In these subjects, the CBG levels at each time-point were significantly lower compared with subjects who had a +30 min total cortisol of >550 nmol/l (P<0.05). To correct for variation in CBG we calculated the total cortisol:CBG ratio and found no significant difference in the +30 min ratio between these two groups. CONCLUSION: CBG varies significantly within and between individuals. This is accompanied by changes in serum total cortisol large enough to affect the outcome of an SST and, by implication, other tests of the HPA axis.


Asunto(s)
Glándulas Suprarrenales/fisiología , Proteínas Portadoras/fisiología , Hipotálamo/fisiología , Hipófisis/fisiología , Adulto , Anciano , Proteínas Portadoras/sangre , Cosintropina , Femenino , Humanos , Hidrocortisona/sangre , Hidrocortisona/orina , Masculino , Persona de Mediana Edad
12.
Drugs Exp Clin Res ; 28(5): 177-83, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12635492

RESUMEN

D-003 is a mixture of very high molecular weight aliphatic primary acids purified from sugar cane (Saccharum officinarum, L.) wax, in which octacosanoic acid is the most abundant component. Previous experimental studies have shown that D-003 not only shows cholesterol-lowering and antiplatelet effects, but also offers strong protection against plasma lipoprotein oxidation. Acute hepatotoxicity induced by CCL4 in rats has been related to an increased rate of lipid peroxidation, and different antioxidant compounds have been revealed to be effective in this model. The aim of this study was to investigate the effects of D-003 in acute hepatotoxicity induced by CCL4 in rats. Male Sprague Dawley rats were randomly distributed in four experimental groups as follows: group 1: negative control rats; group 2: positive control rats (CCL4-treated); groups 3 and 4 rats with liver damage induced by CCL4 and treated with D-003 at 25 and 100 mg/kg, respectively. Acute liver injury was induced by CCL4 suspended in olive oil and intraperitoneally administered at 1 ml/kg. Eighteen hours after CCL4 dosing, the rats were anesthetized with ether and their livers were removed for histopathological studies. D-003 at 25 and 100 mg/kg significantly (p < 0.01) decreased the percentage of ballooned cells and hepatocytes with lipidic inclusions and increased the percentage of normal hepatocytes compared with that in positive controls in a dose-dependent manner. The percent inhibitions of the occurrence of ballooned cells and hepatocytes with lipids were marked (75% and 50%, respectively) with the high dose (100 mg/kg). The percent of turgent hepatocytes was also significantly reduced compared with that in positive controls, but this effect was not dose-dependent. No histological alterations in the liver sections of negative controls were found. Necrotic areas and inflammatory infiltrate were observed in the liver of 7/8 (87.5%) of positive controls. In turn, D-003 dramatically reduced both necrotic areas and inflammatory infiltrate and was present in only 1/8 (12.5%) animals treated with D-003 25 mg/kg and in none (0%) of the animals treated with 100 mg/kg. D-003 protected against the histological changes characteristic of CCL4-induced hepatic injury in rats, in which the process of lipid peroxidation plays the main role. The relationship between this protective action of D-003 on this experimental model and its antioxidant effects needs to be further investigated before definitive conclusions are drawn.


Asunto(s)
Ácidos Grasos/farmacología , Hígado/efectos de los fármacos , Saccharum , Animales , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Tetracloruro de Carbono/farmacología , Enfermedad Hepática Inducida por Sustancias y Drogas , Ácidos Grasos/administración & dosificación , Hepatocitos/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Hígado/lesiones , Hepatopatías/tratamiento farmacológico , Masculino , Fitoterapia , Ratas , Ratas Sprague-Dawley
13.
P R Health Sci J ; 13(1): 13-5, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8016289

RESUMEN

A glucosidase inhibition assay has been used to evaluate extracts from higher plants. An enzyme inhibition of fifty percent or more correlated with the observed cytotoxicity of the extracts.


Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Extractos Vegetales/farmacología , beta-Glucosidasa/antagonistas & inhibidores , Antivirales/farmacología , Muerte Celular/efectos de los fármacos , VIH/efectos de los fármacos , Linfocitos/efectos de los fármacos , Extractos Vegetales/toxicidad , Puerto Rico
14.
P R Health Sci J ; 13(1): 17-8, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7517050

RESUMEN

Extracts from higher plants were evaluated for inhibitory activity against avian myeloblastosis virus reverse transcriptase. The assay may serve as a useful prescreen for potential anti-HIV bioactives.


Asunto(s)
Antivirales/farmacología , Evaluación Preclínica de Medicamentos/métodos , Extractos Vegetales/farmacología , Inhibidores de la Transcriptasa Inversa , Virus de la Mieloblastosis Aviar/enzimología , VIH/efectos de los fármacos , Puerto Rico
15.
J Nat Prod ; 56(8): 1423-5, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8229020

RESUMEN

From the bulbs and leaves of Hymenocallis expansa (Amaryllidaceae), three alkaloid constituents were identified: (+)-tazettine, (+)-hippeastrine, and (-)-haemanthidine. These alkaloids demonstrated significant cytotoxicity when tested against a panel of human and murine tumor cell lines.


Asunto(s)
Alcaloides/farmacología , Alcaloides de Amaryllidaceae , Antineoplásicos Fitogénicos/farmacología , Fenantridinas , Plantas Medicinales/química , Alcaloides/aislamiento & purificación , Animales , Antineoplásicos Fitogénicos/aislamiento & purificación , Línea Celular , Humanos , Ratones , Puerto Rico , Células Tumorales Cultivadas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA